Ypsomed Holding AG (YPSN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CHF
Address
Brunnmattstrasse 6
Burgdorf, BE 3401
Switzerland
Phone
41 34 424 41 11
Website
Sector
Healthcare
Industry
Medical - Specialties
Employees
2042
First IPO Date
September 22, 2004
| Name | Title | Pay | Year Born |
| Simon Michel | CEO, Member of Executive Board & Member of the Board | 1.1M | 1977 |
| Frank Mengis | COO, Deputy CEO Member of Executive Board | 0 | 1964 |
| Ulrike Bauer | Chief Business Officer & Member of Executive Board | 0 | 1969 |
| Nicolas Meyer | Chief Legal Officer & Secretary and Member of Executive Board | 0 | 1971 |
| Michael Zaugg | Chief Corporate Officer & Member of Executive Board | 0 | 1972 |
| Samuel Kunzli | Chief Financial Officer & Member of Executive Board | 0 | 1984 |
| Sam Ghezelbash | Head of Investor Relations & M&A | 0 | N/A |
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.